“…Understanding of this structure-activity relationship of heparin offers the opportunity to develop drugs with higher specificity and better regulation of coagulation and to explore other therapeutic applications such as infection, inflammation, cancer and wound-healing treatment (Linhardt, 2003;Rajangam et al, 2006;Sakiyama-Elbert, 2014;Zhang et al, 2013a;Zhang, Wardwell, & Bader, 2013b). CS/DS chains are composed variably sulfated N-acetylgalactosamine and glucuronic acid or its epimeride iduronic acid disaccharides repeating units (Silbert & Sugumaran, 2002;Takegawa et al, 2011). Growing research evidence reveals the previously less or B i o a c t i v e C a r b o h y d r a t e s a n d D i e t a r y F i b r e 5 ( 2 0 1 5 ) 3 1 -6 1 unperceived functions of CS/DS (Sugahara et al, 2003), for example being a key molecule of the brain extracellular matrix (Kwok, Warren, & Fawcett, 2012), regulating the cell adhesion, proliferation and migration during wound healing (Zou et al, 2004), signaling of growth factor in skeleton (Alliston, 2010).…”